468 related articles for article (PubMed ID: 28153198)
1. Encapsulating Peritoneal Sclerosis.
Alston H; Fan S; Nakayama M
Semin Nephrol; 2017 Jan; 37(1):93-102. PubMed ID: 28153198
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal Membrane Preservation.
Bajo MA; Del Peso G; Teitelbaum I
Semin Nephrol; 2017 Jan; 37(1):77-92. PubMed ID: 28153197
[TBL] [Abstract][Full Text] [Related]
3. Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study.
Nakayama M; Miyazaki M; Honda K; Kasai K; Tomo T; Nakamoto H; Kawanishi H
Perit Dial Int; 2014; 34(7):766-74. PubMed ID: 24497585
[TBL] [Abstract][Full Text] [Related]
4. Recent Understanding of Peritoneal Pathology in Peritoneal Dialysis Patients in Japan.
Hamada C; Tomino Y
Blood Purif; 2021; 50(6):719-728. PubMed ID: 33567422
[TBL] [Abstract][Full Text] [Related]
5. A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent.
Zavvos V; Buxton AT; Evans C; Lambie M; Davies SJ; Topley N; Wilkie M; Summers A; Brenchley P; Goumenos DS; Johnson TS
Kidney Int; 2017 Oct; 92(4):988-1002. PubMed ID: 28673451
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of encapsulating peritoneal sclerosis: lessons from findings of the past three decades in Japan.
Nakayama M; Miyazaki M; Hamada C; Ito Y; Honda K;
Clin Exp Nephrol; 2023 Sep; 27(9):717-727. PubMed ID: 37278945
[TBL] [Abstract][Full Text] [Related]
7. Morphologic characteristics of macroscopic peritoneal finding in patients with peritoneal dialysis.
Hamada C; Nakamoto H; Suzuki Y
J Artif Organs; 2018 Mar; 21(1):102-109. PubMed ID: 28988370
[TBL] [Abstract][Full Text] [Related]
8. Clinical risk factors and outcomes of massive ascites accumulation after discontinuation of peritoneal dialysis.
Chang MS; Chen NC; Hsu CY; Huang CW; Lee PT; Chou KJ; Fang HC; Chen CL
Ren Fail; 2020 Nov; 42(1):1-9. PubMed ID: 31826694
[No Abstract] [Full Text] [Related]
9. Phenotypes of encapsulating peritoneal sclerosis--macroscopic appearance, histologic findings, and outcome.
Latus J; Ulmer C; Fritz P; Rettenmaier B; Biegger D; Lang T; Ott G; Kimmel M; Steurer W; Alscher MD; Segerer S; Braun N
Perit Dial Int; 2013; 33(5):495-502. PubMed ID: 23378473
[TBL] [Abstract][Full Text] [Related]
10. Vasculopathy plays an important role during the development and relapse of encapsulating peritoneal sclerosis with conventional peritoneal dialysis solutions.
Tawada M; Ito Y; Banshodani M; Yamashita M; Shintaku S; Sun T; Suzuki Y; Kinashi H; Kubo Y; Ando M; Yamaguchi M; Katsuno T; Mizuno M; Kawanishi H
Nephrol Dial Transplant; 2021 Jul; 36(8):1519-1526. PubMed ID: 32437531
[TBL] [Abstract][Full Text] [Related]
11. Prospective multicenter observational study of encapsulating peritoneal sclerosis with neutral dialysis solution--the NEXT-PD study.
Kawanishi H; Nakayama M; Miyazaki M; Honda K; Tomo T; Kasai K; Nakamoto H;
Adv Perit Dial; 2010; 26():71-4. PubMed ID: 21348384
[TBL] [Abstract][Full Text] [Related]
12. Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: update from Japan.
Nakayama M; Terawaki H
Int J Urol; 2014 Aug; 21(8):755-61. PubMed ID: 24673567
[TBL] [Abstract][Full Text] [Related]
13. Encapsulating peritoneal sclerosis: what have we learned?
Goodlad C; Brown EA
Semin Nephrol; 2011 Mar; 31(2):183-98. PubMed ID: 21439432
[TBL] [Abstract][Full Text] [Related]
14. Encapsulating peritoneal sclerosis--a complication of peritoneal dialysis.
Chembo C; Macdonald A; Hay N; Matheson P; Pidgeon G; Leikis M
N Z Med J; 2011 Sep; 124(1342):89-93. PubMed ID: 21963929
[TBL] [Abstract][Full Text] [Related]
15. 2009 Japanese Society for Dialysis Therapy guidelines for peritoneal dialysis.
;
Ther Apher Dial; 2010 Dec; 14(6):489-504. PubMed ID: 21118358
[TBL] [Abstract][Full Text] [Related]
16. Additive effectiveness of everolimus plus tamoxifen therapy in treatment of encapsulating peritoneal sclerosis.
Huddam B; Azak A; Koçak G; Başaran M; Voyvoda N; Duranay M
Ren Fail; 2012; 34(3):387-9. PubMed ID: 22263915
[TBL] [Abstract][Full Text] [Related]
17. [Peritoneal dialysis: a time-limited therapy because of encapsulating peritoneal sclerosis?].
Bertoli SV; Musetti C
G Ital Nefrol; 2010; 27(5):464-8. PubMed ID: 20922677
[TBL] [Abstract][Full Text] [Related]
18. Past and present perspectives on encapsulating peritoneal sclerosis.
Kawanishi H; Shintaku S; Banshodani M; Hashimoto S
Contrib Nephrol; 2015; 185():87-97. PubMed ID: 26023018
[TBL] [Abstract][Full Text] [Related]
19. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
[TBL] [Abstract][Full Text] [Related]
20. New Insights into the Effects of Chronic Kidney Failure and Dialysate Exposure on the Peritoneum.
Vlahu CA; Aten J; de Graaff M; van Veen H; Everts V; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2016 11-12; 36(6):614-622. PubMed ID: 27147290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
